Prevalence of the amyloidogenic transthyretin (TTR) V122I allele in 14 333 African-Americans

Amyloid

Volumn 22, Issue 3, 2015, Pages 171-174

  Jacobson, Daniel R ^a,b   Alexander, Alice A ^a   Tagoe, Clement ^c   Buxbaum, Joel N ^d  

^a VA BOSTON HEALTHCARE SYSTEM   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^d SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

African Americans; amyloid cardiomyopathy; transthyretin; TTRV122I

Indexed keywords

DNA; PREALBUMIN;

AFRICAN AMERICAN; ALLELE; ARTICLE; BLOOD SAMPLING; CARDIOVASCULAR RISK; CODON; COHORT ANALYSIS; CONTROLLED STUDY; DNA ISOLATION; GENE FREQUENCY; GENETIC VARIABILITY; GENOTYPE; HEART AMYLOIDOSIS; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; NEWBORN; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; AMINO ACID SUBSTITUTION; AMYLOIDOSIS; DRIED BLOOD SPOT TESTING; ETHNOLOGY; FEMALE; GENE EXPRESSION; GENETICS; GENOTYPING TECHNIQUE; INFANT; MALE; METABOLISM; POINT MUTATION; UNITED STATES;

AFRICAN AMERICANS; ALLELES; AMINO ACID SUBSTITUTION; AMYLOIDOSIS; DRIED BLOOD SPOT TESTING; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENOTYPE; GENOTYPING TECHNIQUES; HUMANS; INFANT; INFANT, NEWBORN; MALE; POINT MUTATION; PREALBUMIN; PREVALENCE; UNITED STATES;

EID: 84940036342     PISSN: 13506129     EISSN: 17442818     Source Type: Journal    
DOI: 10.3109/13506129.2015.1051219     Document Type: Article

References (29)

1. Wallace MR, Naylor SL, Kluve-Beckerman B, Long GL, McDonald L, Shows TB, Benson MD. Localization of the human prealbumin gene to chromosome 18. Biochem Biophys Res Commun 1985;129:753-8.
2. Johnson SM, Connelly S, Fearns C, Powers ET, Kelly JW. The transthyretin amyloidoses: from delineating the molecular mechanism of aggregation linked to pathology to a regulatory-agencyapproved drug. J Mol Biol 2012;421:185-203.
3. Cornwell III GG,, Murdoch WL, Kyle RA, Westermark P, Pitkanen P. Frequency and distribution of senile cardiovascular amyloid. A clinicopathologic correlation. Am J Med 1983;75:618-23.
4. Tanskanen M, Peuralinna T, Polvikoski T, Notkola IL, Sulkava R, Hardy J, Singleton A, et al. Senile systemic amyloidosis affects 25% of the very aged and associates with genetic variation in alpha2-macroglobulin and tau: a population-based autopsy study. Ann Med 2008;40:232-9.
5. Jacobson DR, Pastore RD, Yaghoubian R, Kane I, Gallo G, Buck FS, Buxbaum JN. Variant-sequence transthyretin (isoleucine 122) in late-onset cardiac amyloidosis in black Americans. N Engl J Med 1997;336:466-73.
6. Rowczenio DM, Noor I, Gillmore JD, Lachmann HJ, Whelan C, Hawkins PN, Obici L, et al. Online registry for mutations in hereditary amyloidosis including nomenclature recommendations. Hum Mutat 2014;35:E2403-E12.
7. Gorevic PD, Prelli FC, Wright J, Pras M, Frangione B. Systemic senile amyloidosis. Identification of a new prealbumin (transthyretin) variant in cardiac tissue: immunologic and biochemical similarity to one form of familial amyloidotic polyneuropathy. J Clin Invest 1989;83:836-43.
8. Jacobson DR, Gorevic PD, Buxbaum JN. A homozygous transthyretin variant associated with senile systemic amyloidosis: evidence for a late-onset disease of genetic etiology. Am J Hum Genet 1990;47:127-36.
9. Gillmore JD, Booth DR, Pepys MB, Hawkins PN. Hereditary cardiac amyloidosis associated with the transthyretin Ile122 mutation in a white man. Heart 1999;82:e2.
10. Ammirati E, Marziliano N, Vittori C, Pedrotti P, Bramerio MA, Motta V, Orsini F, et al. The first Caucasian patient with p.Val122Ile mutated-transthyretin cardiac amyloidosis treated with isolated heart transplantation. Amyloid 2012;19:113-17.
11. Asl KH, Nakamura M, Yamashita T, Benson MD. Cardiac amyloidosis associated with the transthyretin Ile122 mutation in a Caucasian family. Amyloid 2001;8:263-9.
12. Jiang X, Buxbaum JN, Kelly JW. The V122I cardiomyopathy variant of transthyretin increases the velocity of rate-limiting tetramer dissociation, resulting in accelerated amyloidosis. Proc Natl Acad Sci USA 2001;98:14943-8.
13. Buxbaum J, Alexander A, Koziol J, Tagoe C, Fox E, Kitzman D. Significance of the amyloidogenic transthyretin Val 122 Ile allele in African Americans in the Arteriosclerosis Risk in Communities (ARIC) and Cardiovascular Health (CHS) Studies. Am Heart J 2010;159:864-70.
14. Buxbaum J, Jacobson DR, Tagoe C, Alexander A, Kitzman DW, Greenberg B, Thaneemit-Chen S, et al. Transthyretin V122I in African Americans with congestive heart failure. J Am Coll Cardiol 2006;47:1724-5.
15. Quarta CC, Buxbaum JN, Shah AM, Falk RH, Claggett B, Kitzman DW, Mosley TH, et al. The Amyloidogenic V122I transthyretin variant in elderly black Americans. N Enl J Med 2015;372:21-9.
16. Jacobson DR, Pastore R, Pool S, Malendowicz S, Kane I, Shivji A, Embury SH, et al. Revised transthyretin Ile 122 allele frequency in African-Americans. Hum Genet 1996;98:236-8.
17. Yamashita T. A prospective evaluation of the transthyretin Ile122 allele frequency in an African-American population. Amyloid 2005;12:127-30.
18. Jacobson DR, Reveille JD, Buxbaum JN. Frequency and genetic background of the position 122 (Val - Ile) variant transthyretin gene in the black population. Am J Hum Genet 1991;49:192-8.
19. Jacobson DR. A specific test for transthyretin 122 (Val-Ile) based on PCR-primer introduced restriction analysis (PCR-PIRA): confirmation of the gene frequency in Blacks. Am J Hum Genet 1992; 50:195-8.
20. Sempos CT. Overview of the Jackson Heart Study: a study of cardiovascular diseases in African American men and women. Am J Med Sci 1999;317:142-6.
21. Fox ER, Musani SK, Barbalic M, Lin H, Yu B, Ogunyankin KO, Smith NL, et al. Genome-wide association study of cardiac structure and systolic function in African Americans: the Candidate Gene Association Resource (CARe) study. Circ Cardiovasc Genet 2013;6:37-46.
22. Victor RG, Haley RW, Willett DL, Peshock RM, Vaeth PC, Leonard D, Basit M, et al. The Dallas Heart Study: a populationbased probability sample for the multidisciplinary study of ethnic differences in cardiovascular health. Am J Cardiol 2004;93: 1473-80.
23. Bryc K, Durand EY, Macpherson JM, Reich D, Mountain JL. The genetic ancestry of African Americans, Latinos, and European Americans across the United States. Am J Hum Genet 2015;96: 37-53.
24. Halder I, Kip KE, Mulukutla SR, Aiyer AN, Marroquin OC, Huggins GS, Reis SE. Biogeographic ancestry, self-identified race, and admixture-phenotype associations in the Heart SCORE Study. Am J Epidemiol 2012;176:146-55.
25. Solovieff N, Hartley SW, Baldwin CT, Klings ES, Gladwin MT, Taylor JG, Kato GJ, et al. Ancestry of African Americans with sickle cell disease. Blood Cells Mol Dis 2011;47:41-5.
26. MacMahon B, Pugh TF. Epidemiology principles and methods. Epidemiol 1970;1:160-2.
27. Afolabi I, Hamidi AK, Nakamura M, Jacobs P, Hendrie H, Benson MD. Transthyretin isoleucine-122 mutation in African and American blacks. Amyloid 2000;7:121-5.
28. Waalen J, Felitti V, Gelbart T, Ho NJ, Beutler E. Prevalence of hemochromatosis-related symptoms among individuals with mutations in the HFE gene. Mayo Clin Proc 2002;77:522-30.
29. Abecasis GR, Altshuler D, Auton A, Brooks LD, Durbin RM, Gibbs RA, Hurles ME, et al. A map of human genome variation from population-scale sequencing. Nature 2010;467:1061-73.